Cutler Group’s Outset Medical OM Stock Holding History

Cutler Group’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7	Closed	-$1K	–	5322
2022 Q2	$1K	Hold	7	–	–	﹤0.01%	4671
2022 Q1	$4K	Buy	+7	New	+$4.21K	﹤0.01%	4304

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EHI

Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Cutler Group's OM Position: Q3 2022 in Review

Cutler Group sold out of Outset Medical (OM) in Q3 2022, closing a stake of 7 shares — an estimated $1K sold.

Cutler Group first reported a position in OM in Q1 2022 and held it in 2 quarters. The position peaked at $4K in Q1 2022. 138 funds tracked by Wall St. Rank hold OM as of Q3 2022.

Cutler Group reported no remaining Outset Medical position as of Q3 2022 after selling out during the quarter.
Cutler Group sold 7 Outset Medical shares in Q3 2022, an estimated $1K.
Cutler Group first reported a position in Outset Medical in Q1 2022 and held it in 2 quarters.
Cutler Group's Outset Medical position peaked at $4K in Q1 2022.
138 funds tracked by Wall St. Rank held Outset Medical as of Q3 2022.

Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.